Jonathan Jay Mazelsky, President and CEO at IDEXX LABORATORIES INC /DE (IDXX), sold 24,000 shares at $575.48 ($13.7M) on 2024-02-07, disclosed to the SEC on 2024-02-09.
Seasonal sale ($13.7M) by President and CEO — this insider has traded IDXX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $571.71 | 5,356 | $3.1M | 22.3% |
| 2 | $571.71 | 5,356 | $3.1M | 22.3% |
| 3 | $572.53 | 4,124 | $2.4M | 17.2% |
| 4 | $572.53 | 4,124 | $2.4M | 17.2% |
| 5 | $573.19 | 462 | $265K | 1.9% |
| 6 | $573.19 | 462 |
| $265K |
| 1.9% |
| 7 | $574.75 | 1,353 | $778K | 5.7% |
| 8 | $574.75 | 1,353 | $778K | 5.7% |
| 9 | $575.48 | 705 | $406K | 3.0% |
| 10 | $575.48 | 705 | $406K | 3.0% |
| Total | $572.61 avg | 24,000 | $13.7M | 100% |
| Filing → |
| IDXX | SELL | 2023-12-06 | $7.3M | — | Filing → |
| IDXX | SELL | 2023-09-05 | $13.7M | — | Filing → |
| IDXX | SELL | 2022-11-16 | $8.9M | — | Filing → |